Y. Fujita‐Yamaguchi

发表

Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

Stephen J. Williams, A. Giordano, P. Scalia, 2022, Cell cycle.

Protein kinase assay by paper-trichloroacetic acid method: high performance using phosphocellulose paper and washing an ensemble of samples on flat sheets.

D. Sahal, Y. Fujita‐Yamaguchi, 1987, Analytical biochemistry.

Combined Effects of Tamoxifen and a Chimeric Humanized Single Chain Antibody against the Type I IGF Receptor on Breast Tumor Growth In vivo

D. Yee, A. Wu, D. Ikle, 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology.

K. Skjødt, E. Rønne, M. Crone, 1985, Progress in allergy.

Visualization of the Insulin Receptor by Immunoblotting

C. Kahn, R. Maron, S. Jacobs, 1984, Diabetes.

Substructural analysis of the insulin receptor by microsequence analyses of limited tryptic fragments isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the absence or presence of dithiothreitol.

R. Paxton, Y. Fujita‐Yamaguchi, Q. Y. Xu, 1990, The Journal of biological chemistry.

Characterization of the insulin receptor kinase purified from human placental membranes.

C. Kahn, M. Kasuga, M. White, 1983, The Journal of biological chemistry.

Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity.

I. Paz, S. Li, Y. Fujita‐Yamaguchi, 1992, Biochemistry.

Solid-phase tyrosine-specific protein kinase assay in multiwell substrate-immobilized polyacrylamide gel.

D. Sahal, Y. Fujita‐Yamaguchi, 1989, Analytical biochemistry.

Structural and Functional Studies on the Purified Insulin Receptor

Y. Fujita‐Yamaguchi, 1987 .

Characterization of phosphatidylinositol kinase activity associated with the insulin receptor.

C. Kahn, G. J. Sale, Y. Fujita‐Yamaguchi, 1986, European journal of biochemistry.

Phosphorylation of fodrin (nonerythroid spectrin) by the purified insulin receptor kinase.

M. Kasuga, E. Nishida, T. Kadowaki, 1985, Biochemical and biophysical research communications.

Differential sensitivity of two functions of the insulin receptor to the associated proteolysis: kinase action and hormone binding.

C. Grunfeld, J. Ramachandran, S. Kathuria, 1986, Proceedings of the National Academy of Sciences of the United States of America.

The monomeric alpha beta form of the insulin receptor exhibits much higher insulin-dependent tyrosine-specific protein kinase activity than the intact alpha 2 beta 2 form of the receptor.

S. Kathuria, Y. Fujita‐Yamaguchi, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of purified insulin receptor subunits.

Y. Fujita‐Yamaguchi, 1984, The Journal of biological chemistry.

Production of Anti-carbohydrate Antibodies by Phage Display Technologies

Wei Zhang, K. Sakai, T. Goto, 2010, The Journal of Biological Chemistry.

Renewed interest in basic and applied research involving monoclonal antibodies against an oncofetal Tn-antigen.

Y. Fujita‐Yamaguchi, 2013, Journal of biochemistry.

Production of Anti-Carbohydrate Antibodies for Cancer Therapeutics or Diagnostics

K. Sakai, Noriyuki Yuasa, Ayano Matsumoto-Takasaki, 2010 .

N-terminal Deletion Mutants of Insulin-like Growth Factor-II (IGF-II) Show Thr and Leu Important for Binding to Insulin and IGF-I Receptors and Leu Critical for All IGF-II Functions (*)

F. Inagaki, H. Terasawa, Ryuji Hashimoto, 1995, The Journal of Biological Chemistry.

The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.

J. Perdue, Y. Marumoto, K. Sakano, 1991, The Journal of biological chemistry.

A monomer-dimer model explains the results of radiation inactivation: binding characteristics of insulin receptor purified from human placenta.

J. Harmon, Y. Fujita‐Yamaguchi, 1988, Biochemistry.

Mass spectrometric revival of an l-rhamnose– and d-galactose–specific lectin from a lost strain of Streptomyces

Y. Yamaguchi, N. Dohmae, T. Hong, 2017, The Journal of Biological Chemistry.

Radiation inactivation experiments predict that a large aggregate form of the insulin receptor is a highly active tyrosine-specific protein kinase.

S. Kathuria, J. Harmon, Y. Fujita‐Yamaguchi, 1989, Biochemistry.

Influenza PR8 HA-specific Fab fragments produced by phage display methods.

M. Matsushita, T. Sata, S. Tamura, 2008, Biochemical and biophysical research communications.

Insulin-like Growth Factor-I Receptors Are Overexpressed and Predict a Low Risk in Human Breast Cancer 1

William, Riccardo, Vincenzo, 2006 .

Radioimmunoassay for human insulin-like growth factor-I receptor: applicability to breast carcinoma specimens and cell lines.

R. Vigneri, O. Ezaki, G. Milazzo, 1991, Metabolism: clinical and experimental.

Recycling of the glucose transporter, the insulin receptor, and insulin in rat adipocytes. Effect of acidtropic agents.

M. Kasuga, O. Ezaki, Y. Akanuma, 1986, The Journal of biological chemistry.

Affinity of anti-insulin-like growth factor Ι receptor antibody binding to the receptor altered by plant lectins.

Y. Kusada, Y. Fujita‐Yamaguchi, 2011, Bioscience trends.

Insulin stimulates the phosphorylation level of v-Ha-ras protein in membrane fraction.

T. Kamata, S. Kathuria, Y. Fujita‐Yamaguchi, 1987, Biochemical and biophysical research communications.

Multiple Transcripts for the Human Cardiac Form of the cGMP-inhibited cAMP Phosphodiesterase (*)

J. Kasuya, H. Goko, Y. Fujita‐Yamaguchi, 1995, The Journal of Biological Chemistry.

Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification.

Y. Fujita-Yamaguchi, I. Goldfine, B. Maddux, 1993, Biochemistry.

Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.

K. Siddle, A. Costantino, A. Belfiore, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phosphorylation of tubulin and microtubule-associated proteins by the purified insulin receptor kinase.

M. Kasuga, E. Nishida, T. Kadowaki, 1985, The Journal of biological chemistry.

Tyrosine-specific protein kinase activity is associated with the purified insulin receptor.

C. Kahn, M. Kasuga, Y. Fujita-Yamaguchi, 1983, Proceedings of the National Academy of Sciences of the United States of America.

A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes.

S. Tamura, T. A. Brown, K. Cheng, 1984, The Journal of biological chemistry.

Removal of sialic acids from the purified insulin receptor results in enhanced insulin-binding and kinase activities.

Y. Fujita-Yamaguchi, S. Kathuria, Y. Sato, 1985, Biochemical and biophysical research communications.

Selective inhibition of the insulin-stimulated phosphorylation of the 95,000 dalton subunit of the insulin receptor by TAME or BAEE.

J. Larner, Y. Fujita-Yamaguchi, S. Tamura, 1984, Biochemical and biophysical research communications.

Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.

H. Nakada, H. Asanuma, K. Tsukamoto, 2012, Journal of biochemistry.

A new assay method for blood group A‐ and B‐glycosyltransferases

A. Yoshida, Y. Fujita‐Yamaguchi, 1979, FEBS letters.

Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta.

D. Sacks, Y. Fujita-Yamaguchi, J. McDonald, 1989, The Biochemical journal.

In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate.

H. Nakano, Y. Fujita-Yamaguchi, J. McDonald, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Purification and characterization of human serum galactosyltransferase (lactose synthetase A protein).

A. Yoshida, Y. Fujita‐Yamaguchi, Akira Yoshida, 1981, The Journal of biological chemistry.

Purification of insulin-like growth factor I receptor from human placental membranes.

P. Cuatrecasas, S. Kathuria, S. Jacobs, 1986, The Journal of biological chemistry.

Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor.

S. Kathuria, Y Fujita-Yamaguchi, S Kathuria, 1988, Biochemical and biophysical research communications.

Production of Single-Chain Variable-Fragments against Carbohydrate Antigens

Y. Fujita-Yamaguchi, Y. Fujita‐Yamaguchi, 2014 .

Purification and refolding of anti-T-antigen single chain antibodies (scFvs) expressed in Escherichia coli as inclusion bodies.

Noriyuki Yuasa, T. Koyama, Y. Fujita‐Yamaguchi, 2014, Bioscience trends.

Characterization of three different single chain antibodies recognizing non-reducing terminal mannose residues expressed in Escherichia coli by an inducible T7 expression system.

Shiuan Chen, H. Nakada, K. Sakai, 2011, Journal of biochemistry.

Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.

A. Takayanagi, N. Shimizu, H. Kawakami, 2010, Journal of biochemistry.

Insulin‐Like Growth Factor (IGF) System Components in Human Prostatic Cancer Cell‐Lines: LNCaP, DU145, and PC‐3 Cells

S. Mohan, Y. Fujita-Yamaguchi, J. Kasuya, 1996, International journal of urology : official journal of the Japanese Urological Association.

The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.

R. Sikes, Shu-lian Li, Jingwen Ye, 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.

S. Mohan, J. Rossi, N. Lee, 1999, Endocrinology.

Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors

S. Wilczynski, G. Kimura, T. Wilson, 1998, Cell and Tissue Research.

Insulin-like effect of trypsin on the phosphorylation of rat adipocyte insulin receptor.

J. Larner, Y. Fujita-Yamaguchi, S. Tamura, 1983, The Journal of biological chemistry.

Affinity Chromatography of Native and Recombinant Proteins from Receptors for Insulin and IGF-I to Recombinant Single Chain Antibodies

Y. Fujita‐Yamaguchi, 2015, Front. Endocrinol..

Expression and structural characterization of anti-T-antigen single-chain antibodies (scFvs) and analysis of their binding to T-antigen by surface plasmon resonance and NMR spectroscopy.

M. Matsushita, Y. Yamaguchi, Y. Fujita-Yamaguchi, 2013, Journal of biochemistry.

Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.

Y. Yamaguchi, S. Hanashima, H. Nakada, 2012, Journal of biochemistry.

Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.

H. Nakada, M. Nakata, Ayano Matsumoto-Takasaki, 2010, Bioscience trends.

Isolation and characterization of anti-T-antigen single chain antibodies from a phage library.

A. Takayanagi, N. Shimizu, H. Kawakami, 2009, Bioscience trends.

Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.

Y. Fujita-Yamaguchi, H. Nakada, H. Asanuma, 2009, Bioscience trends.

Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing 1H7 or 3B7 monoclonal antibody.

Y. Fujita-Yamaguchi, A. Takayanagi, H. Asanuma, 2007, Journal of biochemistry.

Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.

T. Chiba, A. Takayanagi, N. Shimizu, 2007, Biochemistry.

Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies.

Wei Zhang, K. Sakai, M. Nakata, 2007, Biochemistry.

Insulin-like growth factor binding protein production in bovine retinal endothelial cells.

S. Mohan, C. Rotella, P. Romagnani, 1997, Metabolism: clinical and experimental.

Purification of insulin receptor with full binding activity.

K. Itakura, Y. Fujita-Yamaguchi, S. Choi, 1983, The Journal of biological chemistry.

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

D. Yee, Shu-lian Li, Y. Fujita-Yamaguchi, 2003, Cancer research.

Migration of breast cancer cells into reconstituted type I collagen gels assessed via a combination of frozen sectioning and azan staining.

Yo Kamoshida, M. Nakata, Y. Fujita‐Yamaguchi, 2014, Bioscience trends.

Invasion of carcinoma cells into reconstituted type I collagen gels: visual real-time analysis by time-lapse microscopy.

K. Sakai, Y. Inagaki, K Sakai, 2011, Bioscience trends.

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth

A. Wu, Shu-lian Li, Y. Fujita-Yamaguchi, 2000, Cancer Immunology, Immunotherapy.

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

G M Clark, W. McGuire, G. Clark, 1993, Cancer research.

Proteolytic Processing, Maturation, and Unique Synteny of the Streptomyces Hemagglutinin SHA

M. Kalkum, K. Bagramyan, M. Igarashi, 2021, Microbiology spectrum.

Proteolytic Processing, Maturation, and Unique Synteny of the Streptomyces Hemagglutinin SHA

Y. Yamaguchi, K. Bagramyan, M. Igarashi, 2021 .

Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

Y. Fujita-Yamaguchi, T. Sata, T. Kurata, 2007, Vaccine.

Knockdown of AT-rich interaction domain (ARID) 5B gene expression induced AMPKα2 activation in cardiac myocytes.

K. Itakura, Y. Fujita-Yamaguchi, L. Hirose-Yotsuya, 2015, BioScience Trends.

Insulin and Insulin-like Growth Factor-I ( IGF-I ) Receptor Overexpression in Breast Cancers Leads to Insulin / IGF-I Hybrid Receptor Overexpression : Evidence for a Second Mechanism of IGF-I Signaling 1

K. Siddle, A. Costantino, A. Belfiore, 1999 .

The carboxyl‐terminal domain of insulin‐like growth factor‐I receptor interacts with the insulin receptor and activates its protein tyrosine kinase

K. Siddle, D. Leroith, S. Li, 1998, FEBS letters.

The purified COOH-terminal domain of the insulin receptor carries activity to stimulate protein kinase activity or autophosphorylation of the beta subunit domain of insulin receptor.

K. Siddle, J. Kasuya, S. Li, 1994, Biochemical and Biophysical Research Communications - BBRC.

The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain.

S. Giannini, S. Li, S. Liang, 1993, The Journal of biological chemistry.

Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates.

J. Ramachandran, D. Sahal, Y. Fujita‐Yamaguchi, 1988, Archives of biochemistry and biophysics.

Identification of the intact insulin receptor using a sequence-specific antibody directed against the C-terminus of the beta-subunit.

C. Grunfeld, J. Shigenaga, J. Ramachandran, 1987, Endocrinology.

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

D. Yee, Y. Fujita-Yamaguchi, D. Sachdev, 2006, Cancer research.

Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.

Kazuya Yamada, V. Manganiello, H. Onuma, 2003, Molecular genetics and metabolism.

Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.

M. Ohtani, Y. Fujita-Yamaguchi, Y. Yajima, 2009, Bioscience trends.

Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor.

Y. Fujita-Yamaguchi, J. Kasuya, I. Paz, 1993, Biochemical and biophysical research communications.

Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor.

J. Kasuya, S. Li, J. Kato, 1992, Proceedings of the National Academy of Sciences of the United States of America.

An overview of currently available anti-insulin-like growth factor I receptor antibodies.

Y. Fujita-Yamaguchi, Y. Kusada, Y. Fujita‐Yamaguchi, 2007, Bioscience trends.

Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.

S. Vatner, S. Okumura, Y. Ishikawa, 1999, American journal of physiology. Heart and circulatory physiology.

Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.

S. Vatner, S. Okumura, Y. Ishikawa, 1999, The American journal of physiology.

Characterization of human placental cytosolic adenosine 3',5'-monophosphate phosphodiesterase by inhibitors and insulin treatment.

Y. Fujita-Yamaguchi, T. Lebon, L. Xiong, 1990, Endocrinology.

Human glomerular endothelial cells IGFBPs are regulated by IGF-I and TGF-β1

Y. Fujita-Yamaguchi, C. Rotella, A. Ciucci, 1999, Molecular and Cellular Endocrinology.

Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.

Jun Kato, Y. Fujita-Yamaguchi, J. Kato, 1991, Endocrinology.

Antibodies to Insulin-Like Growth Factor I Receptors in Diabetes and Other Disorders

Y. Fujita-Yamaguchi, L. Tappy, G. Boden, 1988, Diabetes.

Purification of Insulin and Insulin-Like Growth Factor (IGF)-I Receptor

Y. Fujita-Yamaguchi, T. Bon, Y. Fujita‐Yamaguchi, 1990 .

A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.

Y. Fujita-Yamaguchi, R. Mineo, E. Fichera, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells.

C. Rotella, A. Ciucci, S. Giannini, 2001, The Journal of endocrinology.

Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine).

D. Sacks, J. McDonald, S. Kathuria, 1989, The Biochemical journal.

Studies on carbohydrate binding to a lectin purified from Streptomyces sp.

K. Imahori, K. Suzuki, K. Oishi, 1982, Biochimica et biophysica acta.

Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.

T. Satoh, Y. Yamaguchi, S. Hanashima, 2012, Protein expression and purification.

Cyclic nucleotide PDE-3

V. Manganiello, Y. Fujita-Yamaguchi, J. Kasuya, 2007, Cell Biochemistry and Biophysics.

Production of a human antibody fragment against the insulin-like growth factor І receptor as a fusion protein.

Y. Fujita-Yamaguchi, A. Takayanagi, N. Shimizu, 2008, Drug discoveries & therapeutics.

Insulin-induced circular membrane ruffling on rat 1 cells expressing a high number of human insulin receptors: circular ruffles caused by rapid actin reorganization exhibit high density of insulin receptors and phosphotyrosines.

Y. Miyata, I. Yahara, Y. Fujita-Yamaguchi, 1993, Experimental cell research.

Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.

H. Nakada, Y. Yajima, N. Masuda, 2012, Bioscience trends.

Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.

I. Goldfine, P. De Meyts, H. Gattner, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats.

Y. Fujita-Yamaguchi, J. Russell, T. Balon, 1998, Diabetes.

Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.

Y. Fujita-Yamaguchi, R. Mineo, E. Fichera, 2000, Biochemical and biophysical research communications.

nonreducing terminal mannose residues for use in immuno- histochemistry

S. Wilczynski, Y. Fujita-Yamaguchi, Wei Zhang, 2007 .

Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

C Collins, A. Ullrich, U. Francke, 1986, The EMBO journal.

Human IGF2 Gene Epigenetic and Transcriptional Regulation: At the Core of Developmental Growth and Tumorigenic Behavior

Stephen J. Williams, P. Scalia, Y. Fujita‐Yamaguchi, 2023, Biomedicines.

PURIFICATION OF PLACENTAL INSULIN RECEPTORS BY THE USE OF INSULIN-DEXTRAN, A SOLUBLE BIOSPECIFIC MACROMOLECULE

Y. Fujita-Yamaguchi, Susumu Suzuki, T. Kuzuya, 1981 .

Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.

T. Akiyama, H. Nakada, Y. Yajima, 2015, BioScience Trends.

MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.

J. Termini, T. Hong, M. Kalkum, 2019, Bioscience trends.

Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.

K. Kabayama, H. Nakada, Y. Yajima, 2013, Bioscience trends.

P-99: Regulation of cAMP phosphodiesterase and DNA synthesis by glucose and insulin in rat vascular smooth muscle cells

J. Kasuya, Y. Fujita‐Yamaguchi, 2009 .

Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene.

K. Kato, V. Manganiello, S. Park, 2000, Biochemical and biophysical research communications.

Comparison of insulin-like growth factor I receptor and insulin receptor purified from human placental membranes.

J. Ramachandran, W. Henzel, S. Kathuria, 1986, The Journal of biological chemistry.

Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.

Y. Fujita-Yamaguchi, L. Tappy, O. Owen, 1988, The Journal of clinical investigation.

An aqueous extract from toad skin prevents gelatinase activities derived from fetal serum albumin and serum-free culture medium of human breast carcinoma MDA-MB-231 cells.

Tomomi Nonaka, M. Nakata, Wei Tang, 2015, Drug discoveries & therapeutics.